Scarica l'app Stockscreener
10.72
3.77%
-0.42
Dopo l'orario di chiusura:
10.53
-0.19
-1.77%
Precedente Chiudi:
$11.14
Aprire:
$11
Volume 24 ore:
937.58K
Relative Volume:
0.85
Capitalizzazione di mercato:
$319.13M
Reddito:
$53.74M
Utile/perdita netta:
$33.24M
Rapporto P/E:
4.0252
EPS:
2.6632
Flusso di cassa netto:
$-27.40M
1 W Prestazione:
-16.25%
1M Prestazione:
-31.59%
6M Prestazione:
+78.96%
1 anno Prestazione:
+502.25%
Intervallo 1D:
$10.54
$11.08
Intervallo di 1 settimana:
$10.54
$12.70
Portata 52W:
$1.69
$23.57
Q 32 Bio Inc Stock (QTTB) Company Profile
Nome
Q 32 Bio Inc
Settore
Industria
Telefono
781-999-0232
Indirizzo
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
10.72 | 331.63M | 53.74M | 33.24M | -27.40M | 2.6632 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | H.C. Wainwright | Buy |
| 2025-02-11 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-12-11 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | Raymond James | Strong Buy |
| 2024-09-11 | Iniziato | Wells Fargo | Overweight |
| 2024-06-17 | Iniziato | Guggenheim | Buy |
| 2024-05-21 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Oppenheimer | Outperform |
| 2024-04-02 | Iniziato | Piper Sandler | Overweight |
| 2023-07-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Reiterato | BTIG Research | Neutral |
| 2022-02-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2020-12-14 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-03-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Iniziato | Chardan Capital Markets | Buy |
| 2019-11-01 | Iniziato | Oppenheimer | Perform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-04-12 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Q 32 Bio Inc Borsa (QTTB) Ultime notizie
QTTB: Q32 Bio Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround - Yahoo Finance
Q32 Bio Inc. (QTTB) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Q32 Bio to present at three major healthcare investor conferences in September 2026 - pluang.com
Q32 Bio to Participate in Upcoming September Investor Conferences - TradingView
Q32 Bio (NASDAQ: FIXX) CFO’s 3,972-share tax sale detailed - Stock Titan
Q32 Bio CFO Lee Kalowski Executes Automatic RSU Tax Withholding Share Sale - Kalkine Media
Q32 Bio CEO Jodie Morrison sells $163,033 in company stock - Investing.com
Q32 Bio CEO Jodie Morrison sells $163,033 in company stock By Investing.com - Investing.com UK
Q32 Bio (FIXX) CEO’s automatic tax sale leaves 343,259 shares - Stock Titan
Q32 Bio: A Deep Dive (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio CEO Jodie Pope Morrison Sells Shares to Cover RSU Tax Withholding - Kalkine Media
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade - qz.com
Morgan Stanley initiates Q32 Bio stock at Overweight on drug potential - Investing.com
Q32 Bio Sees Unusually Large Options Volume (NASDAQ:QTTB) - MarketBeat
Q32 (QTTB) Earnings Snapshot: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Price Move - vinanet.vn
Q32 Bio Company Profile & Introduction - Moomoo
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High? - Yahoo Finance
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Q32 Bio (NASDAQ:QTTB) stock in focus after mid-stage trial data - Kalkine Media
Point72 discloses 4.95% Q32 Bio Inc. (QTTB) holding in Schedule 13G/A - Stock Titan
Q32 Bio Inc. (QTTB) major holders cut reported stake to 0% - Stock Titan
Renaissance Technologies LLC Acquires 107,315 Shares of Q32 Bio Inc. $QTTB - MarketBeat
Q32 Bio (QTTB) Advances 2.34% as Shares Hold Above Key SupportMean Reversion Trade - vinanet.vn
Q32 Bio (QTTB) Holds Near $15.37 as Shares Consolidate Between Key Support and ResistanceGamma Squeeze - vinanet.vn
Q32 Bio Inc (NASDAQ: QTTB) Stock Price, News & Analysis - Kalkine
Q32 Bio Inc (QTTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HC Wainwright Forecasts Q32 Bio's Q3 Earnings (NASDAQ:QTTB) - MarketBeat
Q32 Bio Inc. (NASDAQ:QTTB) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Q32 Bio Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Q32 Bio tops estimates as alopecia drug advances toward late-stage trials (QTTB:NASDAQ) - Seeking Alpha
Q32 Bio Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Inc. posts second quarter 2026 results and updates corporate outlook - Traders Union
Q32 Bio reports Q2 2026 net loss $8.9M, cash $106.3M and $200M July offering - TradingView
Q32 Bio Inc. 2Q 2026: Net loss $(8.95)M, EPS $(0.44) — 10-Q Summary - TradingView
Q32 Bio (Nasdaq: QTTB) adds $187.6M follow-on cash for AA drug - Stock Titan
Q32 Bio (Nasdaq: QTTB) reports AA trial gains and $200M raise - Stock Titan
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Q32 Bio Announces Q2 2026 Financial Results Highlighting Clinical-Stage Progress and Capital Needs - Kalkine Media
Q32 Bio Inc. Revenue Breakdown – NASDAQ:QTTB - TradingView
Q32 Bio Inc expected to post a loss of 54 cents a shareEarnings Preview - TradingView
Q32 Bio Inc. (QTTB) investors disclose 5.49% stake in Schedule 13G/A - Stock Titan
Q32 Bio Inc. SEC Filing (Jul 29, 2026) - Stock Titan
H.C. Wainwright raises Q32 Bio stock price target to $36 on alopecia drug outlook - Investing.com
Q32 Bio Inc (QTTB) Balance Sheet - TradingKey
Q32 Bio Inc (QTTB) Income Statement - TradingKey
Q32 Bio Inc (QTTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Q32 Bio Inc (QTTB) Cash Flow - TradingKey
QTTB|Q32 Bio Inc|Price:15.060|Chg%:-0.150 - TradingKey
QTTB|Q32 Bio Inc|Price:15.140|Chg%:-0.010 - TradingKey
Q32 Bio Inc (QTTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Q 32 Bio Inc Azioni (QTTB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):